J I Esteban
Overview
Explore the profile of J I Esteban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Frias F, Nieto-Aponte L, Gregori J, Garcia-Cehic D, Casillas R, Tabernero D, et al.
Clin Microbiol Infect
. 2017 Feb;
23(10):775.e1-775.e6.
PMID: 28192235
Objectives: This study aimed to characterize the chronically infected general hepatitis C virus (HCV) population in Barcelona using a highly sensitive subtyping method that can identify the 67 recognized HCV...
2.
Llaneras J, Castells L, Santos B, Crespo M, Puig T, Esteban J, et al.
Transpl Infect Dis
. 2016 Apr;
18(3):442-445.
PMID: 27037760
We present a human immunodeficiency virus-infected patient with severe decompensated hepatitis C virus-related cirrhosis awaiting liver transplantation (LT) who received a 24-week course of interferon/ribavirin-free antiviral treatment with sofosbuvir and...
3.
Campos-Varela I, Esteban J, Bes M, Caralt M, Allende H, Rodriguez-Frias F, et al.
J Viral Hepat
. 2014 Mar;
21(10):e118-28.
PMID: 24620835
The success of current antiviral treatment for hepatitis C virus (HCV) recurrence in liver transplant (LT) recipients remains limited. We aimed at evaluating the value of IL28B genotype and early...
4.
Marco A, Esteban J, Sole C, da Silva A, Ortiz J, Roget M, et al.
J Hepatol
. 2013 Mar;
59(1):45-51.
PMID: 23523577
Background & Aims: We estimated HCV reinfection rate and its associated risk factors in inmates with chronic hepatitis C who had achieved sustained virological response (SVR) after completing combination therapy...
5.
Bes M, Sauleda S, Campos-Varela I, Rodriguez-Frias F, Casamitjana N, Homs M, et al.
J Viral Hepat
. 2012 Nov;
19(12):867-71.
PMID: 23121365
Epidemiological, viral and host factors are associated with the outcome of hepatitis C virus (HCV) infection, and strong host immune responses against HCV favour viral clearance. Recently, genome-wide association studies...
6.
Bes M, Sauleda S, Casamitjana N, Piron M, Campos-Varela I, Quer J, et al.
J Viral Hepat
. 2012 Mar;
19(4):283-94.
PMID: 22404727
Hepatitis C virus (HCV)-specific T cell responses are essential for HCV control, and chronic infection is characterized by functionally altered antigen-specific T cells. It has been proposed that the early...
7.
Oporto B, Esteban J, Aduriz G, Juste R, Hurtado A
Zoonoses Public Health
. 2008 Feb;
55(2):73-81.
PMID: 18234025
Three-hundred and forty-five herds (17 swine, 122 dairy sheep, 124 beef and 82 dairy cattle) were investigated for prevalence of Shiga toxin-producing Escherichia coli (STEC). Rectal faecal samples were selectively...
8.
Oporto B, Esteban J, Aduriz G, Juste R, Hurtado A
J Appl Microbiol
. 2007 Sep;
103(4):977-84.
PMID: 17897201
Aims: To determine prevalence and strain diversity of thermophilic campylobacters in healthy ruminants and swine. Methods And Results: Faecal samples collected from 343 herds (120 sheep, 124 beef cattle, 82...
9.
Crespo M, Sauleda S, Esteban J, Juarez A, Ribera E, Andreu A, et al.
J Viral Hepat
. 2007 Mar;
14(4):228-38.
PMID: 17381714
Treatment of chronic hepatitis C in human immunodeficiency virus (HIV)-infected patients is associated with low response rates and high incidence of side effects. One hundred twenty-one hepatitis C virus (HCV)-HIV-coinfected...
10.
Sauleda S, Martorell M, Esteban J, Tural C, Ruiz I, Puig L, et al.
Haemophilia
. 2006 Apr;
12(3):228-36.
PMID: 16643206
The aim of the study was to assess the incidence and the cumulative probability of cytolytic and cholestatic hepatotoxicity during antiretroviral treatment in a group of HIV HCV haemophiliacs. We...